595726 COMPOSITIONS AND METHODS FOR TREATMENT OF AORTIC FIBROSIS Provided is the use of vasoactive intestinal peptide (VIP) with a specified sequence or one or more functional fragments thereof for the manufacture of a medicament for the prophylactic or therapeutic treatment of aortic fibrosis.